Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹6.75Admitted-Finance CORPORATE HOUSE NEAR SOLA BRIDGE S G HIGHWAY THALTEJ AHMEDABAD GUJARAT 380054 | AHMADABAD | GUJARAT | 380054 | ₹6.75 | L1 | Admitted-Finance |
| 2 | L2₹6.97Admitted-Finance | ₹6.97 | L2 | Admitted-Finance |
| 3 | L3₹7.58Admitted-Finance | ₹7.58 | L3 | Admitted-Finance |
| 4 | L4₹9.32Admitted-Finance PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | ₹9.32 | L4 | Admitted-Finance |
| 5 | L5₹9.57Admitted-Finance | ₹9.57 | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Alpha Drugs L3 | Intas Pharmaceuticals ltd L1 | MicronPharmaceuticals L4 | Cipla ltd L7 | BAJAJ HEALTHCARE LIMITED L5 | Sun Pharma Laboratories Ltd L9 | Takeda Biopharmaceuticals India Private Limited L8 | ICHOR BIOLOGICS PRIVATE LIMITED L2 | SUPERMAX DRUGS & PHARMACEUTICALS P LTD L6 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Hemophilia Factors and Chelation Drugs | ||||||||||||
| 1.01 | Factor VIII with vWF 250 IU | 1 | Per IU | 7.58 ₹7.58 | - | - | - | - | - | 9.95 ₹9.95 | - | - |
| 1.02 | Factor VIII SHL Recombinant 250 IU | 1 | Per IU | - | - | - | - | - | - | - | - | - |
| 1.03 | Factor VIII SHL Recombinant 500 IU | 1 | Per IU | - | - | - | - | - | - | - | - | - |
| 1.04 | Factor VIII EHL Recombinant 250 IU | 1 | Per IU | - | - | - | - | - | - | - | - | - |
| 1.05 | Factor VIII EHL Recombinant 500 IU | 1 | Per IU | - | - | - | - | - | - | - | - | - |
| 1.06 | Factor VIII EHL Recombinant 1000 IU | 1 | Per IU | - | - | - | - | - | - | - | - | - |
| 1.07 | Factor IX SHL Plasma Derived 500 IU | 1 | Per IU | - | - | - | - | - | - | - | - | - |
| 1.08 | Factor IX SHL Plasma Derived 600 IU | 1 | Per IU | - | 6.75 ₹6.75 | - | - | - | - | 7.75 ₹7.75 | 6.97 ₹6.97 | - |
| 1.09 | Factor 9 500 IU EHL Rifixia 500 IU | 1 | Per IU | - | - | - | - | - | - | - | - | - |
Updated dates
Tender Value
Refer Docs
Closing Date
23 Feb 2026, 11:30 amClosed
Managing Director PHSC
Managing Director, Punjab Health Systems Corporation, Second Floor, E-Block, Punjab School Education Board Complex, Opposite Fortis Hospital, Phase 8 SAS Nagar Mohali
Hemophilia Drugs and Chelation Drugs
2026_DHFW_158398_1
PHSC/Proc/2025/62
Open Tender
Medical Equipments/Waste
180 days
SAS Nagar Mohali
As per DNIT
3 documents required · 3 mandatory
₹2,000
Exempted
Committee Room of PHSC Mohali
15 Apr 2026
24 Jan 2026
24 Feb 2026
24 Jan 2026
23 Feb 2026
2 Feb 2026
30 Jan 2026
Factor VIII with vWF 250 IU
Factor VIII SHL Recombinant 250 IU
Factor VIII SHL Recombinant 500 IU
Factor VIII EHL Recombinant 250 IU
Factor VIII EHL Recombinant 500 IU
Factor VIII EHL Recombinant 1000 IU
Factor IX SHL Plasma Derived 500 IU
Factor IX SHL Plasma Derived 600 IU
Factor 9 500 IU EHL Rifixia 500 IU
Factor VII Recombinant 1 mg
Non Factor Therapy Inj Emicizumab Recombinant 30 mg
Tab Deferasirox Dispersible 250 mg
Tab Deferasirox Dispersible 500 mg
Tab Deferasirox FCT 180 mg
Tab Deferasirox FCT 360 mg
Cap Deferiprone 250 mg
Cap Deferiprone 500 mg
Inj Desferoxamine 500 mg
Please Enable Macros to View BoQ information
stage.html
html • 0.05 MB
techsummary_321292.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.49 MB
Tendernotice_2.pdf
PDF • 1.18 MB
BOQ_321292.xls
BOQ • 0.34 MB
Download all tender documents and submit your bid